Piramal Pharma Ltd Q3 FY2024-2025 Results: Summary
Revenue | ₹2,233.40Cr |
Net Profits | ₹3.68Cr |
Net Profit Margins | 0.16% |
Highlights
Revenue:
Piramal Pharma Ltd’s revenue jumped 9.8% since last year same period to ₹2,233.40Cr in the Q3 2024-2025. On a quarterly growth basis, Piramal Pharma Ltd has generated -3.74% fall in its revenue since last 3-months.
Net Profits:
Piramal Pharma Ltd’s net profit fell -63.6% since last year same period to ₹3.68Cr in the Q3 2024-2025. On a quarterly growth basis, Piramal Pharma Ltd has generated -83.71% fall in its net profits since last 3-months.
Net Profit Margins:
Piramal Pharma Ltd’s net profit margin fell -66.85% since last year same period to 0.16% in the Q3 2024-2025. On a quarterly growth basis, Piramal Pharma Ltd has generated -83.08% fall in its net profit margins since last 3-months.
